Oruka Therapeutics, Inc.

US$102.86As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ORKAHealthcare
Country USA
PE (Fwd) •••
TSR 2Y CAGR 78.95%
Div yield —
ROE (18.23%)
Biotechnology
Beta (5Y) (0.17)
PE TTM —
TSR TTM 265.14%
Mkt cap US$6.810B
ROIC (13.25%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$108
4.80%
109.35%
Hold 11|0|10|1|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.69
1.69
1.81
1.82
3.62%
6.77%
13.93%
13.91%
Revenue$M
585.9
603.1
635.6
626.9
(3.51%)
1.73%
7.18%
4.57%
Peers (US$6.810B)
Cap (US$)
PE
6.787B
—
6.899B
5.173x
Capital
TTM
5Y
10Y
Leveragex
1.029
0.300
0.280
EBIT/Intx
0.891
0.078
0.071
Own earn%
3.45
30.46
27.34
Sh yield%
8.81
51.31
50.48
Owners
Insiders/Inst%
3.71
75.67
Short interest%
0.83
SBC / revenue%
5.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
3–10
$1 testx
0.0
Incr. ROIC%
3